3412 results for «2022»
3412 results
Commissural alignment during TAVI
13 Sep 2023
As lifetime management of aortic valve disease patients undergoing TAVI is gaining increased attention, this article sought to summarize the principal idea and possible technical implementation of commissural alignment with current generation transcatheter heart valves (THVs).

Author

Author

Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author
Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure
03 Feb 2022
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
01 Sep 2022
Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Author
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.

Author
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author
First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial
03 May 2022
BIOTRONIK's New Absorbable Magnesium Scaffold Achieves Major Milestone in BIOMAG-I Clinical Trial
01 Mar 2022
LimFlow completes enrollment in PROMISE II U.S. Pivotal trial of breakthrough device designed to prevent amputations in no-option patients with chronic limb-threatening ischemia
15 Mar 2022
Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI
05 Apr 2022
This Image in Interventional Cardiology highlights how patient-specific ex vivo simulations offer physicians the opportunity to observe and evaluate the potential in vivo impact of different techniques particularly for complex structural heart interventions.
Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling
28 Jan 2022
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly
28 Jan 2022
Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) arterial disease
11 Feb 2023
BioCardia announces FDA approval of IND application for allogeneic NK1R+ human mesenchymal stem cells for ischemic heart failure
06 Dec 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
24 Oct 2022
P2Y12 inhibitor monotherapy vs DAPT after PCI with BP-EES: The SHARE Randomized Clinical Trial
26 Aug 2023
Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Author
Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement
13 Dec 2023
This case highlights the potential add-on value of reduced-order computational modeling over standard CT scan analysis due to its ability to predict the interaction of different devices or sizes with the patient-specific anatomy.
Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
26 Oct 2023
Data from benchmark registry demonstrate improved TAVR efficiency with preserved patient safety
17 May 2023